Japan’s cardiac marker test market to reach $19m by 2036

The country accounted for 20% of the Asia-Pacific market in 2024.

Japan’s cardiac marker test market is projected to reach $19m by 2036, according to a GlobalData report.

The country accounted for approximately 20% of the Asia-Pacific market in 2024 on the back of its ageing population and robust healthcare infrastructure.

The sector’s growth is attributed to the rising demand for data-driven medical solutions amidst the increasing global burden of cardiovascular diseases.

Traditional methods for assessing heart disease risk are often reactive, depending on symptoms and invasive tests, and may miss early signs in at-risk individuals, said Divya Soni, Medical Devices Analyst at GlobalData.

“An AI-powered platform can fill this gap through non-invasive, multi-omic tests that enhance clinical decision-making while reducing reliance on invasive procedures,” Soni added.